As a subset of regulatory T cells, CD3+CD4−CD8− T cells have therapeutic value for autoimmune disease, depending on their regulatory effects on CD8+ T cells, CD4+ T cells, and B cells[18]. The gene discussed is CD8A; the disease is autoimmune disease.